Which class of medications is commonly used to treat hypertension in patients with renal disease?

The use of ACE inhibitors to treat hypertension in patients with renal disease is supported by their unique mechanism of action, which is particularly beneficial for this population. ACE inhibitors work by inhibiting the angiotensin-converting enzyme, which leads to vasodilation and a subsequent reduction in blood pressure. Additionally, they have renal protective effects, especially in patients with diabetic nephropathy or chronic kidney disease. By reducing glomerular pressure and minimizing the progression of renal damage, ACE inhibitors help preserve renal function while effectively managing hypertension.

Furthermore, they also help decrease proteinuria, which is a common concern in patients with renal disease. The dual benefit of lowering blood pressure and protecting the kidneys makes ACE inhibitors a preferred choice in this context.

While the other classes of medications have their own roles in treating hypertension, they do not offer the same level of renal protection as ACE inhibitors. Therefore, ACE inhibitors stand out as the most appropriate choice for managing hypertension in patients with renal disease.